Norges Bank
PBYI icon

Norges Bank’s Puma Biotechnology PBYI Stock Holding History

Norges Bank’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-321,802
Closed -$2.72M – 2090
2020
Q1 		$2.72M Sell
321,802
-41,400
-11% -$402K ﹤0.01% 1896
2019
Q4 		$3.18M Sell
363,202
-86,015
-19% -$712K ﹤0.01% 1951
2019
Q3 		$4.84M Sell
449,217
-206,220
-31% -$2.23M ﹤0.01% 1917
2019
Q2 		$8.33M Hold
655,437
– – ﹤0.01% 1851
2019
Q1 		$25.4M Sell
655,437
-18,740
-3% -$572K 0.01% 1340
2018
Q4 		$13.7M Sell
674,177
-82,815
-11% -$2.49M 0.01% 1602
2018
Q3 		$34.7M Hold
756,992
– – 0.01% 1153
2018
Q2 		$44.8M Sell
756,992
-96,131
-11% -$5.57M 0.02% 919
2018
Q1 		$58.1M Buy
853,123
+137,120
+19% +$10.3M 0.02% 710
2017
Q4 		$70.8M Buy
716,003
+77,868
+12% +$8.71M 0.03% 614
2017
Q3 		$76.4M Buy
638,135
+136,813
+27% +$12.7M 0.03% 555
2017
Q2 		$43.8M Buy
501,322
+108,443
+28% +$6.07M 0.02% 824
2017
Q1 		$14.6M Buy
392,879
+142,281
+57% +$5.19M 0.01% 1579
2016
Q4 		$7.69M Buy
250,598
+54,424
+28% +$2.35M ﹤0.01% 1782
2016
Q3 		$12.6M Buy
196,174
+71,927
+58% +$3.64M 0.01% 1521
2016
Q2 		$3.7M Sell
124,247
-53,512
-30% -$1.67M ﹤0.01% 1924
2016
Q1 		$5.22M Sell
177,759
-29,117
-14% -$1.32M ﹤0.01% 1810
2015
Q4 		$16.2M Hold
206,876
– – 0.01% 1289
2015
Q3 		$15.6M Sell
206,876
-14,247
-6% -$1.35M 0.01% 1285
2015
Q2 		$25.8M Buy
221,123
+39,011
+21% +$7.06M 0.01% 1036
2015
Q1 		$43M Buy
182,112
+7,211
+4% +$1.54M 0.02% 724
2014
Q4 		$33.1M Buy
174,901
+17,820
+11% +$3.95M 0.02% 872
2014
Q3 		$37.5M Sell
157,081
-141,343
-47% -$29M 0.02% 758
2014
Q2 		$19.7M Buy
+298,424
New +$21.2M 0.01% 1635

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Norges Bank's PBYI Position: Q2 2020 in Review

Norges Bank sold out of Puma Biotechnology (PBYI) in Q2 2020, closing a stake of 321,802 shares — an estimated $2.72M sold.

Norges Bank first reported a position in PBYI in Q2 2014 and held it in 24 quarters. The position peaked at $76.4M in Q3 2017. 128 funds tracked by Wall St. Rank hold PBYI as of Q2 2020.

  • Norges Bank reported no remaining Puma Biotechnology position as of Q2 2020 after selling out during the quarter.
  • Norges Bank sold 321,802 Puma Biotechnology shares in Q2 2020, an estimated $2.72M.
  • Norges Bank first reported a position in Puma Biotechnology in Q2 2014 and held it in 24 quarters.
  • Norges Bank's Puma Biotechnology position peaked at $76.4M in Q3 2017.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2020.

Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.